The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.

Slides:

Advertisements

Similar presentations

Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer.

Advertisements

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Germline Epigenetic Regulation of KILLIN in Cowden.

Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.

KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma Francesca Zammarchi, Mariangela Morelli, Michele Menicagli, Claudio Di.

Figure 1. MORT gene silencing is early event in cancer

Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling Baoping Cao, MD, PhD, Weili Yang,

Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin Agene by Md S. Jamaluddin, Irene Chen, Fan Yang, Xiaohua Jiang, Michael.

KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma Christina Dahl, Cecilie Abildgaard, Rikke Riber-Hansen, Torben Steiniche, Johanne.

Volume 135, Issue 1, Pages e3 (July 2008)

IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.

Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells Youwen Yang, PhD, Hans Michael Haitchi, MD,

Volume 133, Issue 6, Pages (December 2007)

Volume 136, Issue 2, Pages e1 (February 2009)

WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor by Jianming Ying, Hongyu Li, Yun-Wen.

Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.

by Sanjai Sharma, and Alan Lichtenstein

Neal K. Osborn, Hongzhi Zou, Julian R

by Thomas A. Paul, Juraj Bies, Donald Small, and Linda Wolff

Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth Nan He, Kyungtae.

Volume 9, Issue 6, Pages (June 2006)

Volume 129, Issue 1, Pages (July 2005)

Volume 47, Issue 2, Pages (July 2012)

Volume 135, Issue 1, Pages e3 (July 2008)

Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C

Volume 133, Issue 6, Pages (December 2007)

Inhibition of DNA Methylation in the COL1A2 Promoter by Anacardic Acid Prevents UV- Induced Decrease of Type I Procollagen Expression Min-Kyoung Kim,

Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues

miR‐10b locus is hypermethylated in breast cancer. A

Differential DNA Methylation as a Tool for Noninvasive Prenatal Diagnosis (NIPD) of X Chromosome Aneuploidies Floriana Della Ragione, Paola Mastrovito,

S. Sesselmann, M. D. , S. Söder, M. D. , R. Voigt, J. Haag, Ph. D. , S

The Hematopoietic Stem Cell Regulatory Gene Latexin Has Tumor-Suppressive Properties in Malignant Melanoma Viswanathan Muthusamy, Sanjay Premi, Cara.

Volume 42, Issue 4, Pages (April 2005)

Volume 132, Issue 1, Pages (January 2007)

Volume 121, Issue 6, Pages (December 2001)

KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma Christina Dahl, Cecilie Abildgaard, Rikke Riber-Hansen, Torben Steiniche, Johanne.

Volume 137, Issue 1, Pages (July 2009)

Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine Yu-Shan Huang, Yan-Fang Zhi, Shu-Ren Wang

Imprinting at the SMPD1 Locus: Implications for Acid Sphingomyelinase–Deficient Niemann-Pick Disease Calogera M. Simonaro, Jae-Ho Park, Efrat Eliyahu,

Bo-Kuan Wu, Charles Brenner Cell Reports

Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma Soonyean Hwang, Hye-Eun Kim, Michelle Min, Rekha.

Fold Change of hsa-miR-3687 (T/N)(log2)

Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.

Volume 12, Issue 5, Pages (November 2007)

Olivier Humbert, Nancy Maizels Molecular Therapy - Nucleic Acids

Remco van Doorn, Willem H. Zoutman, Nelleke A. Gruis

Core promoter methylation in mediators of adipogenesis.

Volume 17, Issue 1, Pages (January 2007)

Epigenetic Control of the S100A6 (Calcyclin) Gene Expression

Xing-Wei Liang, Ph. D. , Zhao-Jia Ge, M. S. , Lei Guo, Ph. D

Imprinting of Human GRB10 and Its Mutations in Two Patients with Russell-Silver Syndrome Hiroshi Yoshihashi, Katsuhiro Maeyama, Rika Kosaki, Tsutomu.

Volume 131, Issue 6, Pages (December 2006)

Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma

Volume 78, Issue 6, Pages (September 2010)

Molecular Therapy - Nucleic Acids

Volume 25, Issue 11, Pages e6 (December 2018)

TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.

Methylation status of IGFBPL1 in human breast cancer.

PTENP1 expression is downregulated in ccRCC.

Epigenetic regulation of p16INK4a in human gastric cancer.

DNA hypermethylation silences TRAIL in transformed cells.

A, high-resolution methylation analysis of ZNF545 promoter by BGS in representative carcinoma cell lines. A, high-resolution methylation analysis of ZNF545.

The ITGAL promoter is methylated in fibroblasts but not T cells

The ACIN1 Gene is Hypermethylated in Early Stage Lung Adenocarcinoma

SAF-1 expression in clinical breast cancer tissues.

RhoH is underexpressed in HCL mediated by a transcriptional mechanism.

Targeting DCLK1 by miRNA-137.

DNA demethylation reactivates GSN expression in gastric cancer cells.

Methylation of cytosine and consequences of deamination of methyl-C

Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C

Volume 13, Issue 1, Pages (January 2006)

Presentation transcript:

The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. A, GPR109A expression level in matched pairs of human normal colon and colon carcinoma tissues. Colon carcinoma tissues and adjacent normal tissues were collected from 6 patients, and analyzed for GPR109A expression by RT-PCR. GAPDH was used as normalization control. Bottom: the GPR109A levels were quantified using the NIH J program. The ratio of GPR109A versus GAPDH in patient #1 was arbitrarily set at 1. The GPR109A expression levels of the remaining five specimens were then normalized based on patient #1. B, methylation status of the GPR109A gene promoter in human colon carcinoma specimens. Genomic DNA was isolated from colon carcinoma specimens of 5 colon cancer patients and modified with bisulfate. The modified DNA was then analyzed by MS-PCR (U, unmethylated; M, methylated). Numbers above the figure are patient codes. C, inhibition of DNA methylation increases GPR109A expression. SW116 and T84 cells were treated with Aza-dC for 3 days at the indicated doses and analyzed for GPR109A expression level by semiquantitative RT-PCR (top) and real-time RT-PCR (bottom). The GPR109A expression levels of untreated cells were arbitrarily set at 1. Column, mean; bar, SD. D, methylation level of the human GPR109A gene promoter in human colon carcinoma cell lines. The human GPR109A gene DNA sequence was exported from the human genome database and analyzed for CpG islands using MethyPrimer computer program. Top, the human GPR109A gene promoter structure. Vertical bars under the line indicate location of CpG dinucleotides, and the number under the line indicates nucleotide number relative to GPR109A transcription initiation site (+1). Bottom, methylation level of the GPR109A gene promoter in the indicated cell lines. Genomic DNA was modified with bisulfite. The indicated DNA fragment was amplified by PCR and cloned into pCR2.1 vector. Individual clones for each cell line were sequenced, and the methylation level of the cytosine in the CpGs was analyzed using QUMA computer program (open circle, unmethylated CpG; closed circle, methylated CpG). Kankana Bardhan et al. Cancer Immunol Res 2015;3:795-805 ©2015 by American Association for Cancer Research